Fortress Biotech (FBIO) is around the middle of the Biotechnology industry according to InvestorsObserver. FBIO received an overall rating of 44, which means that it scores higher than 44 percent of all stocks. Fortress Biotech also achieved a score of 44 in the Biotechnology industry, putting it above 44 percent of Biotechnology stocks. Biotechnology is ranked 34 out of the 148 industries.
FBIO has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on FBIO!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Fortress Biotech Stock Today?
Fortress Biotech (FBIO) stock is trading at $0.93 as of 11:38 AM on Tuesday, Jan 24, a decline of -$0.06, or -5.97% from the previous closing price of $0.99. The stock has traded between $0.90 and $0.99 so far today. Volume today is below average. So far 283,503 shares have traded compared to average volume of 603,061 shares.
Click Here to get the full Stock Report for Fortress Biotech stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
